thyssenkrupp nucera AG & Co. KGaA (XETRA:NCH2.DE)
| Market Cap | 1.08B-24.5% |
| Revenue (ttm) | n/a-42.5% |
| Net Income | n/a-586.0% |
| EPS | n/a-581.9% |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 16,520 |
| Open | 8.47 |
| Previous Close | 8.53 |
| Day's Range | 8.40 - 8.59 |
| 52-Week Range | 6.87 - 11.65 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About NCH2.DE
thyssenkrupp nucera AG & Co. KGaA engages in the development, engineering, procurement, commissioning, and licensing of electrolysis technologies in Germany, Saudi Arabia, Sweden, the United States, and internationally. It operates through the Chlor-Alkali (CA) and Green Hydrogen (gH2) segments. The company is involved in the development, planning, and construction of new-build electrolysis plants for producing green hydrogen for industrial applications; provision of services for chlor-alkali electrolysis, such as planning and construction of new plants. It also offers the BM 2.7 single-element technology and BiTAC filter press technology. The company was formerly known as thyssenkrupp Uhde Chlorine Engineers GmbH. The company was founded in 1960 and is headquartered in Dortmund, Germany. thyssenkrupp nucera AG & Co. KGaA operates as a subsidiary of thyssenkrupp AG.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$NCH2.DE stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in NCH2.DE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NCH2.DE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NCH2.DE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New NCH2.DE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NCH2.DE from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in NCH2.DE
| ETF | Est. Holding Size |
|---|---|
| VXUSVanguard Total International Stock ETF | $3.13M |
| IEFAiShares Core MSCI EAFE ETF | $2.26M |
| VEAVanguard FTSE Developed Markets ETF | $1.93M |
| SCZiShares MSCI EAFE Small-Cap ETF | $945.40K |
| VSSVanguard FTSE All-World ex-US Small-Cap ETF | $905.50K |
| SCHCSchwab International Small-Cap Equity ETF | $541.56K |
Estimated from each fund’s disclosed top holdings × AUM
NCH2.DE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from NCH2.DE’s recent data — informational, not investment advice